The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.  [electronic resource] 

 -  American journal of ophthalmology  Apr 2001 
 - 457-67 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9394 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9394(01)00840-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Administration, Oral<br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Cidofovir<br/>Cytomegalovirus Retinitis--drug therapy<br/>Cytosine--administration & dosage<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Evaluation<br/>Drug Implants<br/>Female<br/>Ganciclovir--administration & dosage<br/>Humans<br/>Infusions, Parenteral<br/>Kidney--drug effects<br/>Male<br/>Organophosphonates<br/>Organophosphorus Compounds--administration & dosage<br/>Survival Rate<br/>Treatment Outcome<br/>Uveitis--chemically induced<br/>Visual Acuity<br/>Vitreous Hemorrhage--chemically induced